Tech Company Financing Transactions

AdvanDx Funding Round

Merck Global Health Innovation Fund, SLS Invest AB and private investors participated in a $12 million Series B funding round for AdvanDx. The round was announced on 4/9/2014.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

400 Trade Ctr. 6990
Woburn, MA 01801
USA

Phone

(781) 376-0009

Website

www.advandx.com

Email Address

[email protected]

Overview

Rapid diagnostics for critical infections. Improving antibiotic decisions and patient outcomes.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Dennis Langer

        

Chief Financial Officer

Tucker Kelly

        

VP - Bus. Development

James Coull

        

Browse more venture capital transactions:

Prev: 4/9/2014: Certified Security Solutions venture capital transaction
Next: 4/9/2014: Lithium Technologies venture capital transaction

Share this article

Where The Data Comes From

We report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary